|
PIGC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.526200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.562600E-01 |
| Normal-vs-Stage2 |
5.171200E-01 |
| Normal-vs-Stage3 |
3.651200E-01 |
| Normal-vs-Stage4 |
4.890000E-01 |
| Stage1-vs-Stage2 |
5.794200E-01 |
| Stage1-vs-Stage3 |
1.075840E-01 |
| Stage1-vs-Stage4 |
5.527600E-01 |
| Stage2-vs-Stage3 |
1.395630E-01 |
| Stage2-vs-Stage4 |
9.679400E-01 |
| Stage3-vs-Stage4 |
7.269700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.626400E-01 |
| Normal-vs-AfricanAmerican |
6.777400E-01 |
| Normal-vs-Asian |
7.798400E-01 |
| Caucasian-vs-AfricanAmerican |
4.227600E-01 |
| Caucasian-vs-Asian |
6.784000E-01 |
| AfricanAmerican-vs-Asian |
9.245400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.071800E-01 |
| Normal-vs-Female |
4.824000E-01 |
| Male-vs-Female |
2.204000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.116000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.310000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.953400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.890600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.309800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.015200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.387200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.028800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.037000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.962600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.423400E-01 |
| Normal-vs-Grade 2 |
4.442200E-01 |
| Normal-vs-Grade 3 |
8.673000E-01 |
| Normal-vs-Grade 4 |
7.544400E-01 |
| Grade 1-vs-Grade 2 |
3.458200E-01 |
| Grade 1-vs-Grade 3 |
1.900250E-01 |
| Grade 1-vs-Grade 4 |
1.855970E-01 |
| Grade 2-vs-Grade 3 |
1.885410E-01 |
| Grade 2-vs-Grade 4 |
2.304000E-01 |
| Grade 3-vs-Grade 4 |
8.243400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.137400E-01 |
| Normal-vs-ccB subtype |
2.738400E-01 |
| ccA subtype-vs-ccB subtype |
4.167900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.816800E-01 |
| Normal-vs-N1 |
3.102400E-01 |
| N0-vs-N1 |
2.950000E-01 |
|
|
